A Bio-Matrix spokesperson noted that the Cord Blood/Bio-Matrix alliance will:

-- Have what both companies see as the highest level stem cell banking facility in the country

-- Offer an opportunity to bank adult adipose stem cells, which show great promise for future therapies

-- Leverage on each of the companies strengths within the stem cell banking industry

"We are very excited about the alliance with Cord Blood America and believe that this Business Alliance is an excellent fit for us. This Business Alliance will add significant value and benefits to our marketplace," stated Brian Pockett, Managing Director & COO of Bio-Matrix Scientific Group Inc.

About Cord Blood America

Cord Blood America, Inc. is a publicly traded company, governed by the United States Securities & Exchange Commission. Cord Blood America's stock trades on the NASDAQ OTC Bulletin Board under the symbol: CBAI. Cord Blood America has established itself as the platinum standard national competitor in the umbilical cord blood storage industry.

About Bio-Matrix Scientific Group Inc.

Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) are Cord Blood America (OTCBB:CBAI), StemCells Inc. (NASDAQ:STEM) and Cryo-Cell International Inc. (OTCBB:CCEL).

More information will be available shortly on the Company's website: www.BMXGonline.com

DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.